Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Baseline characteristics of the SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) multidomain dementia prevention randomized controlled trial and insights from the recruitment process.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Posterior Cortical Atrophy in the Asia-Pacific: A Report From the PCA Asian Workgroup.

Annals of clinical and translational neurology·2026
Same author

ReCOGnAIze app to detect vascular cognitive impairment and mild cognitive impairment.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging.

The journal of prevention of Alzheimer's disease·2026
Same author

A regional framework for the detection and management of ARIA with anti-amyloid therapies in early Alzheimer's disease in Asia.

The journal of prevention of Alzheimer's disease·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Ashwati Vipin1, Gurveen Kaur Sandhu2, Rasyiqah Binte Shaik Mohamed Salim3

  • 1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

高化-tau 181 (p-tau181) 与通过白质超强度 (WMH) 减少灰质 (GM) 脑 perfusion 有关. 这表明p-tau181可能通过影响大脑血液流动而导致痴呆风险.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 神经成像是一种神经成像.

背景情况:

  • 减少大脑输液是认知能力下降和痴呆症的标志.
  • 像Aβ1-40这样的等离子体生物标志物和神经炎症标志物与血管衰老有关.
  • 大脑血流 (CBF) 变化与核心病理 (Aβ1-40,tau) 之间的关系尚未完全理解.

研究的目的:

  • 为了研究血Aβ1-40,酸化-tau 181 (p-tau181) 和年龄对大脑输液的影响.
  • 探索白质超强度 (WMH) 和质纤维酸蛋白 (GFAP) 在这些关系中的调解作用.
  • 阐明影响灰质 (GM) perfusion 的直接和间接因果途径.

主要方法:

  • 利用了来自新加坡生物标志物和认知队列研究的数据.
  • 雇佣的横截面动脉脊柱标记输液MRI和血生物标志物的评估 (p-tau181,Aβ1-40,GFAP).
  • 进行了路径分析,以建模预测因子 (p-tau181,Aβ1-40,年龄),调解因子 (WMH,GFAP) 和结果 (GM输液) 之间的关系.

主要成果:

  • p-tau181和年龄显著预测了GFAP和WMH.
  • 增加的WMH体积与减少的GM perfusion有关.
  • 观察到p-tau181对转基因输液有显著的间接作用,由WMH介导,表明p-tau181通过WMH促进了低输液.

结论:

  • p-tau181和年龄间接通过WMH和GFAP影响转基因输液.
  • 增加的p-tau181似乎通过增加WMH负担对转基因低 perfusion 有因果作用.
  • 这些发现突出了潜在的途径,将tau病理与与痴呆风险相关的脑血管变化联系起来.